Advocate Medical Group-Park Ridge ( Site 0025)

Park Ridge, Illinois 60068

Use our guide to learn which trials are right for you!

We've found
3 trials
at this facility
Triple Negative Breast Cancer (TNBC) Clinical Trial
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355)
Status: Enrolling, Phase III
Updated: 4/26/2018
mi
from
Park Ridge, IL
Click here to add this to my saved trials
Melanoma Clinical Trial
Safety and Efficacy of Pembrolizumab Compared to Placebo in Resected High-risk Stage II Melanoma (MK-3475-716/KEYNOTE-716)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Park Ridge, IL
Click here to add this to my saved trials
Advanced Melanoma Clinical Trial
Efficacy and Safety of Lenvatinib (E7080/MK-7902) Plus Pembrolizumab (MK-3475) for Advanced Melanoma in Anti-Programmed Death-1/Programmed Death-Ligand 1 (PD-1/L1)-Exposed Participants (MK-7902-004/E7080-G000-225/LEAP-004)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Park Ridge, IL
Click here to add this to my saved trials